Large retrosternal parathyroid carcinoma with primary hyperparathyroidism.

Area of Science:

• Endocrinology
• Oncology
• Surgical Pathology

Background:

• Parathyroid carcinoma is a rare endocrine malignancy, accounting for less than 1% of hyperparathyroidism cases.
• It is characterized by parathyroid hormone (PTH)-dependent hypercalcemia, posing significant morbidity and mortality risks.
• Early recognition and surgical intervention are crucial for improving patient prognosis.

Observation:

• Clinical indicators suggesting parathyroid carcinoma include markedly elevated serum calcium, PTH, and alkaline phosphatase levels.
• A palpable neck mass, along with renal and skeletal manifestations, raises suspicion for parathyroid carcinoma.
• Diagnosis requires correlation of histopathology with clinical findings, as histology alone is insufficient.

Findings:

• Complete resection of the primary tumor is the most effective initial treatment.
• Repeated surgical operations can be beneficial for managing recurrent disease.
• Prognosis for parathyroid carcinoma is variable, with 5-year survival rates ranging from 40% to 86% and a 10-year survival rate around 49%.

Implications:

• This case highlights the importance of considering parathyroid carcinoma in the differential diagnosis of hypercalcemic disorders.
• Prompt diagnosis and surgical management are essential for optimizing outcomes in patients with parathyroid carcinoma.
• Further research into diagnostic and therapeutic strategies for parathyroid carcinoma may improve survival rates.